Turnover of pharmaceuticals in Norway 2018, by ATC main groups

The pharmaceuticals belonging to ATC main group L, Antineoplastic and immunomodulating agents, generated the highest turnover in Norway in 2018, with a value of around 6.8 billion Norwegian kroner. The ATC main group with the second highest turnover was group N, which is drugs used for nervous system. The turnover from pharmaceuticals in this ATC main group was around 4.2 billion Norwegian kroner.

Turnover of pharmaceuticals in Norway in 2018, by ATC main groups

Turnover in million NOK
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Norway

Survey time period

2018

Supplementary notes

*excluding sex hormones and insulin

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical market in Norway "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.